Weight Loss

GLP-1 agents single agonist Semaglutide (Ozempic) used for treatment of type 2 diabetes and anti-obesity and to reduce cardiovascular events. Binds to GLP-1 with a two fold great affinity than Tirzepatide lowers hunger, good noise and delayed gastric emptying

GIP-GLP-1 receptor agonist (Monjaro) approved for weight managment with obesity and weight related conditions. decreases nausea and increases white adipose fat loss.

GLP-3 retatrutide a partial GLP-1 agonist, full GIP agonist and partial GCG agonist. Brown adipose thermogenisis, cardio protective and weight loss with muscle preserving abilities along with insulin resistant and metabolic health.